A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials
Abstract Personalized cancer therapy seeks to tailor treatment to an individual patient’s biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/966915397e484ccb974449090e63c828 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:966915397e484ccb974449090e63c828 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:966915397e484ccb974449090e63c8282021-12-02T11:52:15ZA Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials10.1038/s41598-017-05003-x2045-2322https://doaj.org/article/966915397e484ccb974449090e63c8282017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05003-xhttps://doaj.org/toc/2045-2322Abstract Personalized cancer therapy seeks to tailor treatment to an individual patient’s biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal toxicity, esophageal expansion, as a method to quantify radiosensitivity in 134 non-small-cell lung cancer patients, by using K-Means clustering to group patients based on esophageal radiosensitivity. Patients within the cluster of higher response and lower dose were labelled as radiosensitive. This information was used as a variable in toxicity prediction modelling (lasso logistic regression). The resultant model performance was quantified and compared to toxicity prediction modelling without utilizing radiosensitivity information. The esophageal expansion-response was highly variable between patients, even for similar radiation doses. K-Means clustering was able to identify three patient subgroups of radiosensitivity: radiosensitive, radio-normal, and radioresistant groups. Inclusion of the radiosensitive variable improved lasso logistic regression models compared to model performance without radiosensitivity information. Esophageal radiosensitivity can be quantified using esophageal expansion and K-Means clustering to improve toxicity prediction modelling. Finally, this methodology may be applied in clinical trials to validate pre-treatment biomarkers of esophageal toxicity.Joshua S. NiedzielskiJinzhong YangFrancesco StingoZhongxing LiaoDaniel GomezRadhe MohanMary MartelTina BriereLaurence CourtNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Joshua S. Niedzielski Jinzhong Yang Francesco Stingo Zhongxing Liao Daniel Gomez Radhe Mohan Mary Martel Tina Briere Laurence Court A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials |
description |
Abstract Personalized cancer therapy seeks to tailor treatment to an individual patient’s biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal toxicity, esophageal expansion, as a method to quantify radiosensitivity in 134 non-small-cell lung cancer patients, by using K-Means clustering to group patients based on esophageal radiosensitivity. Patients within the cluster of higher response and lower dose were labelled as radiosensitive. This information was used as a variable in toxicity prediction modelling (lasso logistic regression). The resultant model performance was quantified and compared to toxicity prediction modelling without utilizing radiosensitivity information. The esophageal expansion-response was highly variable between patients, even for similar radiation doses. K-Means clustering was able to identify three patient subgroups of radiosensitivity: radiosensitive, radio-normal, and radioresistant groups. Inclusion of the radiosensitive variable improved lasso logistic regression models compared to model performance without radiosensitivity information. Esophageal radiosensitivity can be quantified using esophageal expansion and K-Means clustering to improve toxicity prediction modelling. Finally, this methodology may be applied in clinical trials to validate pre-treatment biomarkers of esophageal toxicity. |
format |
article |
author |
Joshua S. Niedzielski Jinzhong Yang Francesco Stingo Zhongxing Liao Daniel Gomez Radhe Mohan Mary Martel Tina Briere Laurence Court |
author_facet |
Joshua S. Niedzielski Jinzhong Yang Francesco Stingo Zhongxing Liao Daniel Gomez Radhe Mohan Mary Martel Tina Briere Laurence Court |
author_sort |
Joshua S. Niedzielski |
title |
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials |
title_short |
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials |
title_full |
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials |
title_fullStr |
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials |
title_full_unstemmed |
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials |
title_sort |
novel methodology using ct imaging biomarkers to quantify radiation sensitivity in the esophagus with application to clinical trials |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/966915397e484ccb974449090e63c828 |
work_keys_str_mv |
AT joshuasniedzielski anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT jinzhongyang anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT francescostingo anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT zhongxingliao anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT danielgomez anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT radhemohan anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT marymartel anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT tinabriere anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT laurencecourt anovelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT joshuasniedzielski novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT jinzhongyang novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT francescostingo novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT zhongxingliao novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT danielgomez novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT radhemohan novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT marymartel novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT tinabriere novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials AT laurencecourt novelmethodologyusingctimagingbiomarkerstoquantifyradiationsensitivityintheesophaguswithapplicationtoclinicaltrials |
_version_ |
1718395117949157376 |